Citation Impact
Citing Papers
Forecasting the Impact of Heart Failure in the United States
2013 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy
2011
Acute kidney injury
2012 Standout
Acute renal failure after exercise in a child with renal hypouricemia
1995
Molecular identification of a renal urate–anion exchanger that regulates blood urate levels
2002 StandoutNature
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Oral Hydration and Alkalinization is Noninferior to Intravenous Therapy for Prevention of Contrast‐Induced Nephropathy in Patients with Chronic Kidney Disease
2010
Age and origin of the G774A mutation inSLC22A12causing renal hypouricemia in Japanese
2008
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Exercise Standards for Testing and Training
2013 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Acute renal failure after exercise in a child with renal hypouricaemia
1993
Trends in Heart Failure Incidence and Survival in a Community-Based Population
2004 Standout
The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm
2017 Standout
Myocarditis
2011 Standout
Prophylaxis Strategies for Contrast-Induced Nephropathy
2006
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Systematic Review and Meta-analysis
2008 Standout
Quantification of meropenem in plasma and cerebrospinal fluid by micellar electrokinetic capillary chromatography and application in bacterial meningitis patients
2007
Principles of antibacterial dosing in continuous renal replacement therapy
2009
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
2005 Standout
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
2007 Standout
Should we use diuretics in acute renal failure?
2004
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
2007 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
KDIGO Clinical Practice Guidelines for Acute Kidney Injury
2012 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
The dawning era of polymer therapeutics
2003 Standout
Prevention of radiocontrast nephropathy
2005
Myocarditis
2009 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Preventing Nephropathy Induced by Contrast Medium
2006
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Myocarditis
2006 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)
2013 Standout
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
Origin of the PSEN1 E280A mutation causing early‐onset Alzheimer's disease
2013 StandoutNobel
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Guidelines for the Primary Prevention of Stroke
2014 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Contrast-Induced Nephropathy
2006
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone
1999
Works of C. Erley being referenced
Acute renal failure due to uric acid nephropathy in a patient with renal hypouricemia
1989
What is the best hydration regimen to prevent contrast media-induced nephrotoxicity?
2004
Comparative Pharmacokinetics and Pharmacodynamics of Loop Diuretics in Renal Failure
1994
Calcium salts of ketoacids as a new treatment strategy for uremic hyperphosphatemia.
1989
Pharmacokinetics of Meropenem in Critically Ill Patients with Acute Renal Failure Treated by Continuous Hemodiafiltration
1998